Gene therapy towards a clinical trial for gamma-sarcoglycanopathy, limb-girdle muscular dystrophy
Gamma-sarcoglycanopathy (LGMD2C) is one of the most common limb-girdle myopathies. It affects less than 10 people per 1,000,000 and is characterized by progressive muscle weakness...










